Trials / Not Yet Recruiting
Not Yet RecruitingNCT07194291
Menses&Change in Diabetic Girl
Menstrual Cycle Changes in Adolescent Girls With Diabetes
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 10 Years – 20 Years
- Healthy volunteers
- Not accepted
Summary
To assess menstraul cycle changes in adolescent girls with diabetes and to find out the various risk factors
Detailed description
Type 1 diabetes mellitus (T1DM) is the result of autoimmunity mediated destruction of pancreatic beta cells, ultimately causing insulin deficiency and, consequently, hyperglycemia . Typically the diagnosis of T1DM is made in childhood or adolescence,but about 40% of affected individuals are diagnosed in adulthood. Hyperglycemia-related complications can contribute to impairment of endocrine axes, such as the hypothalamic pituitary gonadal (HPG) axis . Historically, before the introduction of insulin replacement therapy, prepubertal girls wh developed T1DM rarely showed normal sexual development, exhibiting primary amenorrhea . Although the introduction of insulin drastically changed the natural history of T1DM, allowing restoration of the HPG physiology, menarche delay remained as a typical sign in girls with T1DM . In addition, women with T1DM report a higher incidence of menstrual irregularities \>30% compared with control subjects without diabetes . Accordingly, signs and symptoms of androgen excess, such as acne and hirsutism, are more frequent in women with T1DM than in their age-matched counterparts These interconnected abnormalities contribute to the reduced fertility observed in women with T1DM, as characterized by fewer pregnancies and live births and earlier menopause compared with women without diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Follow up of female sexual function | We follow up menstrual changes in diabetic adolescent girls to improve the outcome |
Timeline
- Start date
- 2025-10-01
- Primary completion
- 2026-10-01
- Completion
- 2026-12-01
- First posted
- 2025-09-26
- Last updated
- 2025-09-26
Source: ClinicalTrials.gov record NCT07194291. Inclusion in this directory is not an endorsement.